Clinical Trials | June 13, 2026
Ryvu advances romaciclib program as FDA clears AML trial expansion
The regulatory decision follows promising results from RIVER-81
The regulatory decision follows promising results from RIVER-81
Approval is based on results from the phase 3 OASIS 4 clinical trial
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
The award places the company in the top 5% globally
Subscribe To Our Newsletter & Stay Updated
